|
|
Blood, 29 January 2009, Vol. 113, No. 5, pp. 1097-1104.
Prepublished online as a Blood First Edition Paper on October 21, 2008; DOI 10.1182/blood-2008-05-158477.
Previous Article | Table of Contents | Next Article 
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
STIM1 is essential for Fc receptor activation and autoimmune inflammation
Attila Braun1,*,
J. Engelbert Gessner2,*,
David Varga-Szabo1,
Shahzad N. Syed2,
Stephanie Konrad2,
David Stegner1,
Timo Vögtle1,
Reinhold E. Schmidt2, and
Bernhard Nieswandt1,3
1 Rudolf Virchow Center, Deutsche Forschungsgemeinschaft (DFG) Research Center for Experimental Biomedicine, University of Würzburg, Würzburg;
2 Molecular Immunology Research Unit, Clinic for Immunology and Rheumatology, Hannover Medical School, Hannover; and
3 Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany
Fc receptors (Fc Rs) on mononuclear phagocytes trigger autoantibody and immune complex–induced diseases through coupling the self-reactive immunoglobulin G (IgG) response to innate effector pathways, such as phagocytosis, and the recruitment of inflammatory cells. FcR -based activation is critical in the pathogenesis of these diseases, although the contribution of Fc R-mediated calcium signaling in autoimmune injury is unclear. Here we show that macrophages lacking the endoplasmic reticulum–resident calcium sensor, STIM1, cannot activate Fc R-induced Ca2+ entry and phagocytosis. As a direct consequence, STIM1 deficiency results in resistance to experimental immune thrombocytopenia and anaphylaxis, autoimmune hemolytic anemia, and acute pneumonitis. These results establish STIM1 as a novel and essential component of Fc R activation and also indicate that inhibition of STIM1-dependent signaling might become a new strategy to prevent or treat IgG-dependent immunologic diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|
|